As of Apr 17
| -0.02 / -1.15%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 2.50. The median estimate represents a +132.56% increase from the last price of 1.72.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.